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Abstract  
The neural crest (NC) is a remarkable transient structure generated during early vertebrate 
development. The neural crest progenitors have extensive migratory capacity and 
multipotency, harboring stem cell-like characteristics such as self-renewal. They can 
differentiate into a variety of cell types from craniofacial skeletal tissues to the trunk 
peripheral nervous system (PNS). Multiple regulators such as signaling factors, transcription 
factors, and migration machinery components are expressed at different stages of NC 
development. Gain- and loss-of-function studies in various vertebrate species revealed 
epistatic relationships of these molecules that could be assembled into a gene regulatory 
network defining the processes of NC induction, specification, migration, and differentiation. 
These basic developmental studies led to the subsequent establishment and molecular 
validation of neural crest stem cells (NCSCs) derived by various strategies. We provide here 
an overview of the isolation and characterization of NCSCs from embryonic, fetal, and adult 
tissues; the experimental strategies for the derivation of NCSCs from embryonic stem cells, 
induced pluripotent stem cells, and skin fibroblasts; and recent developments in the use of 
patient-derived NCSCs for modeling and treating neurocristopathies. We discuss future 
research on further refinement of the culture conditions required for the differentiation of 
pluripotent stem cells into axial-specific NC progenitors and their derivatives, developing 
non-viral approaches for the generation of induced NC cells (NCCs), and using a genomic 
editing approach to correct genetic mutations in patient-derived NCSCs for transplantation 
therapy. These future endeavors should facilitate the therapeutic applications of NCSCs in the 
clinical setting.    
  
Keywords: Neural crest stem cells; Induced pluripotent stem cells; Human embryonic stem 
cells; Melanocytes; Mesenchymal. 
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Introduction 
The neural crest (NC) represents a transient cell population with stem cell-like properties that 
emerges from the dorsal neural plate border during gastrulation. Molecular signals derived 
from the non-neural ectoderm and underlying mesoderm play essential roles in the 
specification of the border region where multipotent NC stem cells (NCSCs) are formed. 
These neuroepithelial NCSCs then undergo a process called epithelial-mesenchymal 
transition (EMT), in which cell-cell adhesion and cytoarchitecture are altered leading to 
mesenchymal migration as they delaminate from the dorsal neuroepithelium (or premigratory 
NC domain). Depending on their axial origin and environmental guidance cues, multipotent 
NCSCs migrate along stereotypical routes to different locations in the embryo, where they 
can differentiate into various cell types, including ectomesenchymal tissue (cartilage and 
bones), sensory neurons and enteric ganglia in the PNS, melanocytes in the skin, and smooth 
muscle cells in the cardiac outflow tract (LeDouarin and Kalcheim, 1999). The NC 
development involves a cascade of molecules that are functionally linked and can be 
integrated into a gene regulatory network that define the processes at different developmental 
stages. Genetic mutations can result in dysregulated NC development leading to many 
congenital human diseases, such as cardiovascular defects, craniofacial abnormities, and 
intestinal aganglionosis, collectively known as neurocristopathies (Mayor and Theveneau, 
2013). The identification and isolation of multipotent NCSCs derived from adult tissues, 
embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and skin fibroblasts 
provide promising cellular sources for the treatments of neurocristopathies. In this review, we 
provide an overview of the molecular regulation involved in different NC developmental 
stages; strategies for the isolation and characterization of NCSCs from embryonic, fetal, and 
adult tissues; specific strategies to differentiate pluripotent stem cells or reprogram somatic 
cells into NCSCs; and their therapeutic potential for treating neurocristopathies.  
 
Molecular network of neural crest induction and epithelial-mesenchymal transition 
(EMT) 
The process of NC induction starts at the early gastrula stage and continues through to neural 
tube (NT) closure. Tissue grafting experiments in amphibian and chick embryos showed that 
NC was formed via interactions between the neural plate and the non-neural ectoderm 
(Mancilla and Mayor, 1996; Selleck and Bronner-Fraser, 1995). Meanwhile, NCCs could be 
induced in vitro via interactions between the paraxial mesoderm and neural plate (Bonstein et 
al., 1998; Selleck and Bronner-Fraser, 1995). Gain- and loss-of-function studies in the mouse, 
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chick, frog, and zebrafish demonstrated that several signaling molecules including BMP, Wnt, 
Notch/Delta, and FGF were involved in the induction of NC within the neural plate border 
region (Chang and Hemmati-Brivanlou, 1998; Endo et al., 2002; Garcia-Castro et al., 2002; 
Glavic et al., 2004; Ikeya et al., 1997; Kengaku and Okamoto, 1993; LaBonne and Bronner-
Fraser, 1998; Lewis et al., 2004; Liem et al., 1997; Liem et al., 1995; Marchant et al., 1998; 
Mayor et al., 1997; Monsoro-Burq et al., 2003; Nguyen et al., 1998). Although the timing and 
relative importance of these signaling molecules varies among the species, it is believed the 
integated action of these signaling molecules is crucial for establishing the neural plate border 
region distinct from the neural and non-neural ectoderm. The neural plate border cells 
respond to early inductive signals by expressing a distinct set of transcription factors termed 
neural plate border specifiers, such as Tfap2, Msx1, Zic1, Pax3, and Pax7 (Bang et al., 1997; 
Garnett et al., 2012; Knight et al., 2003; Mansouri et al., 1996; Marchal et al., 2009; Mitchell 
et al., 1991; Streit and Stern, 1999). Once these factors are initiated, they maintain their 
expression via regulatory interactions with each other (Bhat et al., 2013; Monsoro-Burq et al., 
2005). They cooperate with the NC signaling pathways to specify NC progenitors within the 
neural plate border by activating the expression of NC specifier genes, such as those 
encoding Snail, FoxD3, and SoxE family (mainly Sox9 and Sox10) transcription factors 
(Cheung and Briscoe, 2003; Plouhinec et al., 2014; Simoes-Costa et al., 2014; Simoes-Costa 
et al., 2012). Several functional studies in various animal models have demonstrated these 
molecules are important in defining NC identity (Cheung and Briscoe, 2003; Dottori et al., 
2001; Mayor et al., 1995; Mori-Akiyama et al., 2003; Nieto et al., 1994; Sasai et al., 2001). 
Overexpression or knockdown of one NC specifier generally affected the expression of 
another, indicating that like neural plate border specifiers, the NC specifier genes form an 
interconnected regulatory loop, believed to be crucial for maintaining NC progenitors in a 
multipotent state (Aybar et al., 2003; Cheung et al., 2005; Honore et al., 2003; O'Donnell et 
al., 2006). Recently, Labonne’s group further revealed that some NC regulators (Id3, TFAP2, 
Ets1, FoxD3, and Snail1) were co-expressed with the core pluripotency factors in Xenopus 
blastula cells and promoted pluripotency in both NC and blastula cells. These results suggest 
that NCCs differentiated from a subset of blastula cells still retained pluripotent potential and 
had greater plasticity for developmental cell fate than previously anticipated (Buitrago-
Delgado et al., 2015).  
 
The NC specifiers have an additional function of conferring NC progenitors with the ability 
to undergo EMT through alteration of cell-cell adhesion and regulation of Rho GTPases, 
		
	 5	
essential for remodeling actin cytoskeleton dynamics (Cheung et al., 2005; Liu and Jessell, 
1998; Sit and Manser, 2011). Previous studies showed that Snail2 directly repressed 
cadherin6B, which is a prerequisite for EMT in cranial NCCs (Coles et al., 2007; Taneyhill et 
al., 2007). Further studies revealed that Smad-interacting protein 1 (Sip1), a transcriptional 
repressor, was a critical requirement for cells to become fully mesenchymal via the regulation 
of the switch from E-cadherin to N-cadherin (N-Cad) during cranial NC EMT (Rogers et al., 
2013). In addition, Sip1 regulated FoxD3 expression, which was shown to inhibit N-Cad 
expression, while upregulating integrin β1, laminin, and cadherin 7 in trunk NC, indicating 
that Sip1 indirectly regulated N-Cad via FoxD3 in cranial NCCs (Cheung et al., 2005; Rogers 
et al., 2013). Besides its function to specify NC identity, Sox9 also cooperates with Snail2 to 
promote EMT by inducing morphological change and migratory behavior in trunk NCCs 
(Cheung et al., 2005; Liu et al., 2013). Therefore, the combined expressions of NC specifier 
genes can define the characteristics of delaminating NCCs. To determine how Sox9 and 
Snail2 exert their influence on NC motility, new effectors will need to be identified by 
transcriptional profiling of sorted GFP+ cells using RNA-seq. Gain- and loss-of function 
studies can be used to validate the epistatic relationships of these effectors within the 
transcriptional network, although they cannot distinguish between direct and indirect 
transcriptional regulation.  
 
Comparative genomic analysis across different species identified conserved and functional 
enhancers containing sequence-specific binding motifs for direct transcriptional input that 
triggered the expression of NC specifiers. For example, Sox10 expression in cranial NCCs 
was directly regulated by Sox9, c-Myb, and Ets-1 (Betancur et al., 2010), while Ets-1 
expression was further subjected to transcriptional regulation by tfap2, Msx1/2, and Pax7 
(Barembaum and Bronner, 2013). In addition, dissection of FoxD3 non-coding genomic 
elements revealed two separate enhancers NC1 and NC2, which triggered its expression in 
cranial and trunk NCCs, respectively. Interestingly, Pax7 and Msx1/2 functioned as common 
inputs to both enhancers, where axial specificity was determined by cranial Ets-1 and trunk 
Zic1, which exhibited high posterior to low anterior gradient expression (Simoes-Costa et al., 
2012). Recently, Simoes-Costa and Bronner took advantage of these two enhancers to isolate 
pure populations of NCCs for comparative transcriptional profiling (Simoes-Costa and 
Bronner, 2016). RNA-seq analysis comparing the two different cell populations revealed 
enrichment of genes in the cranial NCCs. Each regulator was individually knocked down to 
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establish a hierarchical order of the cranial-specific gene regulatory network at early and later 
time points in the development. Importantly, some of these cranial-specific transcriptional 
regulator genes, Sox8, Tfap2b, and Ets1, were able to reprogram trunk NCCs into 
chondrogenic lineage, which are normally generated only by cranial NCCs. These findings 
indicate the plasticity of NCC fate, in which the axial identity and lineages can be driven by 
transcriptional regulators. Together, these functional and enhancer studies establishing direct 
transcriptional relationships between regulators have been used to assemble the NC gene 
regulatory network comprising nested sub-modules that define the distinct developmental 
events of specification, delamination, migration, and differentiation.   
 
Neural crest derivatives and their signaling regulation 
The delaminated NCCs undergo extensive migration following stereotypical routes 
throughout the embryo to eventually settle and differentiate (LeDouarin and Kalcheim, 1999; 
Trainor, 2013), which is mediated largely by their axial origin within the NT and by the 
myriad of complex environmental cues they encounter during migration. Cranial NCCs 
derived from the mid-diencephalon to somite 5 exhibit a unique differentiation capacity by 
forming craniofacial structures of the head including cartilage and bone tissues in the skull, 
facial, and pharyngeal skeleton, but they can also differentiate into cranial neurons, glia, and 
connective tissues of the face. The trunk NCCs, which arise from the NT caudal to the somite 
5, initially migrate through the anterior portion of sclerotome, where they form the dorsal 
root ganglia (DRG) containing sensory neurons and satellite glia. Some of them further 
migrate to form Schwann cells along the spinal nerves, sympathetic ganglia, and endocrine 
cells of the adrenal gland. A subset of trunk NCCs then take a dorsolateral route beneath the 
skin to form pigment-producing melanocytes. Another population of trunk NCCs lying 
opposite to somites 1-7 (vagal) and posterior to somite 28 (sacral) contribute to the formation 
of enteric ganglia throughout the length of the gut. Finally, cardiac NCCs derived from 
somites 1-3 that overlap with the anterior portion of the vagal region form the muscle and 
connective tissue in walls of large arteries and the septum in the outflow tract.  
 
Besides the importance of genetic determinants in regulating specific rostral-caudal identities 
of NCCs, environmental cues along the migratory path play crucial roles in directing the 
differentiation of NC progenitors into different lineages at their destination. A similar set of 
signaling molecules to those involved in NC induction also play important roles in NC 
differentiation. For example, activation and inhibition of canonical Wnt signaling in NC 
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progenitors resulted in promoting and inhibiting sensory neuron formation, respectively (Hari 
et al., 2002; Lee et al., 2004). In addition, BMP2 and BMP4 secreted by the dorsal aorta 
induced NCCs to differentiate into sympathetic neurons (Schneider et al., 1999; Shah et al., 
1996; Varley and Maxwell, 1996). Meanwhile, FGF signaling was found to play a crucial 
role in determining the skeletogenic fate of cranial NCCs. Functional studies in mice and 
chick demonstrated that FGF secreted by the pharyngeal ectoderm induced cranial NCCs 
expressing Fgf receptor 1 to differentiate into cartilage tissue in the branchial arches (John et 
al., 2011; Li et al., 2010; Partanen et al., 1998; Sarkar et al., 2001). Finally, Delta/Notch 
signaling mediated lateral inhibition resulting in the neuron-glial fate of NC progenitors in 
the DRG (Wakamatsu et al., 2000).  
 
Developmental potency of neural crest precursors 
The remarkable differentiation capacity of NCCs underlies their multipotency. The diversity 
of NC-derived lineages was first demonstrated by Le Douarin et al., who used chick-quail 
chimeras to establish the sites of origin of NC derivatives generated along the anterior-
posterior axis of embryos (LeDouarin and Kalcheim, 1999). Subsequent heterotrophic 
transplantations before the onset of migration, in which chick neural domain was replaced 
with quail neural primordium from a different axial level, showed that quail NCCs destined 
to be adrenergic neurons acquired cholinergic identity. This indicates that premigratory 
NCCs are not pre-determined to a particular cell fate, rather they appear to be specified by 
environmental signals and multiple cellular interactions during migration (Le Douarin et al., 
1975). However, these transplantation experiments revealed only the plasticity of bulk NCC 
fate at a particular axial level, but not the developmental potential of a single NCC. To 
resolve this issue, an in vitro clonogenic assay was established, which demonstrated the 
existence of multipotent quail NCCs that gave rise to at least two progeny, melanocytes and 
neuronal cells (Sieber-Blum and Cohen, 1980). Consistently, these cultured single NCCs 
were able to migrate like their endogenous counterparts, and differentiate into melanocytes 
and neurons when placed in a chick embryonic environment (Bronner-Fraser et al., 1980), 
indicating that some premigratory NCCs were multipotent. Recently, culture conditions 
(bFGF, retinoic acid, and IGF1) were established to maintain chick premigratory NCCs as 
“crestospheres” that could self-renew and remain in a multipotent state for 7 weeks. 
Heterogeneous and dynamic expressions of NC markers, Sox10 and FoxD3, in crestospheres 
indicated a subpopulation of the crestosphere cells (~10%) were multipotent NCSCs with 
self-renewal capacity, whereas the rest were fate-restricted NC precursors (Kerosuo et al., 
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2015). It is possible that culture conditions could alter and probably introduce bias to the 
developmental fate of NCCs, which may not reflect the in vivo situation. To demonstrate the 
presence of multipotent NCCs in vivo, cell lineage tracing studies were conducted on 
premigratory and migratory trunk NCCs in avian embryos using either vital fluorescence dye 
or retroviral vectors expressing marker proteins. These studies showed the majority of the 
labeled clones were multipotent before and after delamination, as their descendants could 
generate more than one differentiated cell type (Bronner-Fraser and Fraser, 1989; Bronner-
Fraser and Fraser, 1988; Frank and Sanes, 1991; Fraser and Bronner-Fraser, 1991). Similarly, 
in vivo dye injection into single premigratory trunk NCCs in mouse (Serbedzija et al., 1994), 
Xenopus (Collazo et al., 1993), and zebrafish embryos (Raible and Eisen, 1994) revealed 
multipotent clones, although the proportions varied between species. Both in vitro 
clonal/crestosphere analysis and in vivo lineage tracing studies demonstrated that many 
individual premigratory and migratory NCCs were multipotent.  
 
The stochastic labeling of premigratory NCCs by microinjection also resulted in the 
identification of clones that were fate-restricted to a single cell type (Bronner-Fraser and 
Fraser, 1989; Bronner-Fraser and Fraser, 1988). Indeed, previous studies in cultured trunk 
NCCs suggested that a major portion of the initial NC population contained a heterogeneous 
mixture of neuronal and glial precursors followed by melanogenic lineages (Erickson and 
Reedy, 1998; Henion and Weston, 1997). The order of trunk NC derivative generation was 
consistent with results from a discrete lineage analysis of cells in the dorsal NT, in which 
early emerging cells migrated ventrally to generate sympathetic ganglia, Schwann cells in the 
peripheral nerves, neurons, and glial in the DRG, while late emerging cells migrated 
dorsolaterally to generate melanocytes (Erickson et al., 1992; Serbedzija et al., 1989). This 
stereotypical ventral to dorsal order of colonization of NC derivatives appeared to be 
determined by the spatiotemporal location of NC progenitors within the premigratory domain 
of the NT, in which most dorsal cells that were first to delaminate generated ventral 
derivatives, while ventral cells emigrating later generated melanocytes (Krispin et al., 2010). 
However, the cell labeling experiment was performed in an open book culture of NT that 
may not reflect the cell behavior in vivo. Recent studies using in vivo cell labeling and time-
lapse imaging confirmed no correlation between ventrodorsal movement of premigratory NC 
precursors and their fate restriction, and cells from different subregions of the dorsal NT were 
equipotent in their ability to differentiate into specific trunk derivatives (McKinney et al., 
2013). Although there is no strict correlation between the choice of NC derivatives and the 
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position of their progenitors in the dorsal NT, both studies demonstrated that the NC was 
comprised of a heterogeneous population of fate-restricted progenitors before departure from 
the NT, whereas previous single cell lineage experiments in vivo showed premigratory NCCs 
were multipotent (Bronner-Fraser and Fraser, 1988). These discrepancies could be due to 
differences in the timing of cell labeling in the NT. Cell labeling was performed in the chick 
NT at stage 10-17 in Bronner-Fraser’s study, at stage 14 in Krispin’s study and at stage 13-17 
in Mckinney’s study. It is possible that labeling primitive neuroectodermal progenitors (in 
Bronner-Fraser’s study) in early stages prior to segregation between NT and NC lineages 
resulted in more labeled single cells contributing to multiple cell types, whereas labeling cells 
in later stages (all three studies) resulted in more labeled fate-restricted premigratory NCCs. 
In vivo time-laspe imaging of single trunk premigratory NCCs labeled at stage 10-17 may be 
able to resolve these issues. This approach was supported by a recent in vivo fate mapping 
study of single trunk NCCs in a R26R-Confetti mouse model that demonstrated most of the 
premigratory and postmigratory murine NC populations were multipotent (Baggiolini et al., 
2015). 
 
Isolation and characterization of embryonic NCSCs 
The ability of an undifferentiated NC population to undergo self-renewal and acquire 
progressive lineage restriction for different cell types fulfils the basic criteria for stem cells. 
Therefore, multipotent NCCs have “stemness” properties, whereas NC progenitors are fate-
restricted precursor cells that are either unipotent (form one lineage) or bipotent (form two 
lineages).  
 
The idea of NC stem cells (NCSCs) was originally proposed by Stemple and Anderson, who 
used flow cytometry to isolate a rodent NC population that expressed a low affinity nerve 
growth factor receptor (NTR) p75NTR. These p75NTR+ cells were able to self-renew to form 
colonies and could generate neurons and glia in the PNS and myofibroblasts (Stemple and 
Anderson, 1992). The same research group also fractionated E14.5 rat fetal sciatic nerve into 
five distinct subpopulations using flow cytometry with antibodies against p75NTR and P0 
(marker for peripheral myelin protein). One of the enriched p75NTR+P0- subfractions 
exhibited self-renewal capacity, and formed multipotent colonies that gave rise to neurons, 
Schwann cells, and smooth muscle-like myofibroblasts in vitro. Upon transplantation, these 
post-migratory NCSCs generated neurons and glia in diverse regions of the PNS in chick 
embryo, demonstrating the persistence of multipotency of NSCSs in postmigratory targets of 
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embryonic NC (Morrison et al., 1999; White et al., 2001). The DRG is another target site 
containing substantial amounts of p75NTR+P0+ or p75NTR+PMP22+ NCSCs that could generate 
multilineage colonies of glia, neurons, and smooth muscle-like cells, each of which increased 
in response to NRG1 (neuregulin1), BMP2, and TGF-β, respectively. Whether they undergo 
self-renewal has not been assessed (Hagedorn et al., 1999). In contrast, p75NTR-/lowP0+ 
populations isolated from sciatic nerve generated smooth muscle cells, indicating that cells 
expressing P0 exhibited differentiation potential other than glial lineage (Morrison et al., 
1999). Similarly, P0 and PMP22, both major components of peripheral myelin, were 
expressed in the glial lineage long before myelination, and were markers for the 
differentiation of multipotent NCSCs into neurons, glia, and smooth muscle-like cells in the 
embryonic DRG in response to instructive extracellular cues (Hagedorn et al., 1999). Another 
postmigratory NCSC population was derived from E14.5 embryonic rat gut by flow 
cytometry enrichment using antibodies against cell surface proteins p75NTR and α4 integrin. 
Upon plating 1% to 2% of the sorted cells for culture, only 60% survived to form colonies, 
and 80% of these differentiated into neurons, glia and myofibroblasts, indicating the colonies 
derived from embryonic gut were multipotent NCSCs (Iwashita et al., 2003). It is important 
to note that the NCSCs isolated from different postmigratory target sites were intrinsically 
different, underlying their differentiation potentials. In normal development, gut-derived 
NCSCs are biased toward a neuronal fate, whereas sciatic nerve-derived NCSCs are biased 
toward a glial fate (Kubu et al., 2002); however, both cell types remained multipotent in vitro 
and were able to generate neurons and glia upon transplantation in diverse locations in chick 
embryos (Bixby et al., 2002; Mosher et al., 2007). Although neurogenic and gliogenic factors 
were expressed in these two tissue-specific NCSCs, gut-derived NCSCs were more sensitive 
to the neurogenic effects of BMP4 than sciatic nerve derived NCSCs. In contrast, sciatic 
nerve-derived NCSCs exhibited a stronger response to the gliogenic effects of soluble Delta 
than gut-derived NCSCs. These results demonstrated that cell-intrinsic differences encoded in 
NCSCs and regional environmental influences determine the generated cell types in different 
embryonic locations (Bixby et al., 2002). In addition to the trunk NCSCs, an undifferentiated 
progenitor population derived from early migratory cranial NCCs in mouse and chick 
embryos also exhibited self-renewal capacity and differentiated into diverse cell types such as 
neurons, melanocytes, osteocytes, and chondrocytes (Calloni et al., 2009; Chung et al., 2009; 
Zhao et al., 2006). 
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Characterization of adult tissue-derived NCSCs and their regenerative potential 
Multipotent NCSCs have been identified not only in the early embryonic stage but also in 
adulthood. The discovery of NCSCs in multiple rodent and human adult tissues including 
DRG (Li et al., 2007), bone marrow (BM) (Shi et al., 2016), whisker pad (WP) (Nagoshi et 
al., 2008), skin (Toma et al., 2001; Wong et al., 2006), gut (Kruger et al., 2002), carotid body 
(CB) (Pardal et al., 2007), heart (Tomita et al., 2005), and several cranial tissues such as the 
cornea (Brandl et al., 2009), iris (Kikuchi et al., 2011), dental pulp (Janebodin et al., 2011), 
hard palate (Widera et al., 2009), and oral mucosa (Davies et al., 2010) provide potential 
attractive sources of cells for replacement therapy (Fig. 1).  
 
BM-, DRG-, and WP-derived NCSCs 
In addition to the surface markers for the prospective isolation of NCSCs from various 
embryonic and adult tissues (Morrison et al., 1999; Nagoshi et al., 2008; Stemple and 
Anderson, 1992), transgenic mice carrying NC-specific expression of Cre recombinase with 
continuously activated floxed-EGFP reporter driven by P0 and Wnt1 promoter-sequences 
were used to derive NCSCs from the BM, DRG, and WP by flow cytometry (Nagoshi et al., 
2008). Besides being a marker for Schwann cell lineage (Lemke et al., 1988), P0 is also 
expressed in migrating NCCs like Wnt1 at E10.5 of mouse embryos (Jiang et al., 2000; 
Nagoshi et al., 2008). When cultured at the same density, DRG-derived EGFP+ NCSCs 
generated the highest number of primary and secondary spheres consistent with high 
expression levels of NCSC marker genes (p75NTR, Sox10, Nestin, and Musashi1) compared 
with BM and WP. In addition, most of the DRG-derived spheres (74.6%) showed trilineage 
differentiation potential (neurons, glia, and myofibroblasts) compared to WP-derived spheres 
(7.3%) and BM-derived spheres (3.3%), indicating that DRG contained the highest 
proportion of NCSCs. These results support the previous view that tissue-dependent signals 
also conferred intrinsic differences in the adult NCSCs in terms of their differentiation 
potency and self-renewal capacity.  
 
CB-derived NCSCs  
The carotid body is another tissue with therapeutic value as a potential source of cells. It is an 
oxygen-sensing organ located at the bifurcation of carotid artery, which contains clusters of 
O2-sensitive, neuron-like glomus cells enveloped by glial cells. They support organ growth 
during acclimatization to sustained hypoxia (Pardal et al., 2007). Genetic lineage tracing 
studies using a Wnt1-Cre reporter line demonstrated the glial cells were multipotent stem 
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cells of NC origin. These CB stem cells were able to form neurospheres, self-renew, and 
differentiate into dopaminergic neurons and smooth muscle cells both in vitro and in vivo. 
Interestingly, activation of CB stem cells in hypoxia by adjacent glomus cells induced 
switching of phenotypes from glial (GFAP+) to Nestin+ proliferative intermediate progenitors, 
which in turn differentiated into glomus cells and other cell types (Pardal et al., 2007). 
Because of their highly dopaminergic nature, glomus cells have been successfully used in 
transplantation studies in animal models of Parkinson’s disease (PD) with promising results 
(Munoz-Manchado et al., 2013; Villadiego et al., 2005). However, the small amount of 
available tissue in the CB limits its use in transplantation. Therefore, expansion of CB 
progenitors in vitro from resident adult stem cells could provide sufficient quantities of cells 
to differentiate into glomus cells for the treatment of PD. These studies demonstrate for the 
first time a potential physiological application of adult NCSCs in vivo.  
 
Cardiac-derived NCSCs 
Cardiac NCCs participate in the septation of the cardiac outflow tract into the aorta and 
pulmonary artery (Kirby et al., 1983). In vitro clonal analysis of the cardiac NC population 
emigrated from NT explants revealed only a small fraction of them were NCSCs capable of 
self-renewal and generating various NC derivatives (Ito and Sieber-Blum, 1991; Youn et al., 
2003), but whether these cells exhibit long-term self-renewal capacity remains to be 
determined. Cardiac NCSCs were identified in fetal and adult heart within the cardiac side 
population (SP). SP cells are found in various tissue types and are considered to be tissue 
specific progenitors that are mostly dormant. Stem cell fractions from rodent neonatal heart, 
which were enriched and expanded in culture as proliferating cardiospheres, were found to 
express undifferentiated markers, Nestin and Musashi-1. In addition, cardiosphere-initiating 
cells were found within neonatal and adult cardiac non-myocyte cell populations. Cells 
dissociated from cardiospheres could differentiate into NC-derived cell types such as PNS 
neurons, glia and smooth muscle cells, and cardiomyocytes. When transplanted into the 
migration staging area between the neural tube and somite of chick embryos, many 
cardiosphere-derived cells behaved like NCCs by following normal migratory routes and 
contributing to trunk derivatives. Lineage analysis using P0-Cre/Floxed EGFP double 
transgenic mice revealed that the NC contributed to some of the dormant cardiosphere-
initiating cells, which remained as resident stem cells in the adult heart (Tomita et al., 2005). 
This finding was supported in a recent study using high-resolution genetic fate-mapping 
approaches with cKitCreERT2/+ and Wnt1:Flpe mouse lines to show that cKit delineates cardiac 
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NC progenitors, which possess the full capacity to generate cardiomyocytes and other cardiac 
NC derivatives (Hatzistergos et al., 2015). In another study, a subpopulation of resident 
cardiac progenitors expressing Nestin migrated to the infarct region following ischemic 
damage and contributed to reparative vascularization (El-Helou et al., 2008; El-Helou et al., 
2013). Therefore, understanding the molecular regulation involved in the establishment and 
maintenance of these stem/progenitor populations, as well as how they differentiate into 
target tissues could be of therapeutic value for the treatment of various heart diseases. 
 
Gut-derived NCSCs 
Fetal gut-derived NCSCs can be enriched by antibodies against p75NTR and α4 integrin 
(Nagoshi et al., 2008). These cells persisted in the gut of adult rodents (Kruger et al., 2002) 
and could be isolated to a high purity by positive selection using CD49b (integrin α2) 
(Joseph et al., 2011). The sorted CD49b+ cells expressed markers characteristics of NCSCs 
(p75, Sox10, and Nestin) and enteric glia (S100B and GFAP). Immunofluorescence staining 
revealed that 60% of enteric glia were positive for CD49b, but only 44% of cells formed 
multipotent primary neurospheres in culture, indicating heterogeneity of adult enteric glia. 
Upon dissociation into single cells, primary neurospheres could generate secondary 
neurospheres, indicating their ability to self-renew. However, multipotent enteric progenitors 
derived from the fetal gut exhibited a greater degree of self-renewal and differentiation 
capacity compared to adult gut progenitor cells (Kruger et al., 2002; Mosher et al., 2007). 
After transplantation into chick embryos, the former cells gave rise to mainly neurons, 
whereas the latter differentiated into predominantly glia (White and Anderson, 1999). Further 
probing of the physiological role of Cd49b+ NCSCs in the adult gut revealed they were fated 
to form mainly glia instead of neurons under steady-state conditions and after injury (Joseph 
et al., 2011). In vivo grafting of fetal or postnatal intestinal NC-derived neurospheres into the 
colon of postnatal mice showed the cells derived from these neurospheres could migrate, 
proliferate, and generate ganglion-like clusters with neurochemical, morphological, and 
electrophysiological properties of enteric neurons, and were able to receive synaptic input 
(Dettmann et al., 2014; Hotta et al., 2013). These studies indicated that progenitor cells 
isolated from the postnatal gut might have therapeutic potential for the treatment of enteric 
nervous system (ENS) disorders. However, further proof of concept studies (e.g., 
transplanting cells isolated from adult mouse gut into adult mice) are needed to demonstrate 
that gut-derived NCSCs can be used to treat adult enteric neuropathies.  
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Skin-derived NCSCs 
The identification and isolation of multipotent progenitors from the skin of adult rodents and 
humans is an important discovery in the field of adult stem cells because skin tissue is readily 
available (Fernandes et al., 2004; Sieber-Blum et al., 2004; Toma et al., 2001; Toma et al., 
2005). Using Wnt1-Cre reporter mice, genetic lineage tracing of skin-derived precursors 
(SKPs), which reside in the base of facial hair follicles and dermal papillae, revealed they 
were of NC origin (Fernandes et al., 2004; Sieber-Blum et al., 2004). They expressed genes 
(Snail1/2, Pax3, Twist, and Sox9, but not Sox10 or p75NTR) characteristics of embryonic NC 
precursors with self-renewal capacity and multipotency to differentiate into neurons, smooth 
muscle cells, Schwann cells, and melanocytes in vitro. Furthermore, transplantation of SKP-
derived neurospheres into chick embryos showed they dispersed along NC migratory routes 
and colonized NC-derived structures such as the DRG and the peripheral nerve (Fernandes et 
al., 2004). Whereas facial SKPs are derived from the NC, trunk SKPs originate from 
somite/mesenchymal tissues as shown in somite-specific Myf5-Cre/Floxed-YFP (Jinno et al., 
2010) and dermal-specific Dermo1-Cre/Floxed-YFP reporter mice (Jinno et al., 2010; Krause 
et al., 2014). Despite the distinct tissue origins, both trunk and facial SKPs are very similar at 
the transcriptome level, and have similar differentiation potentials and functional properties.  
Another multipotent cell population of NC origin, termed epidermal NCSCs, was identified 
in the adult mouse bulge region of whisker follicle (Nagoshi et al., 2008; Sieber-Blum et al., 
2004). Although found in different locations, these cells behaved similarly to SKPs with the 
ability to self-renew and differentiate into various NC derivatives. Gene expression profiling 
identified a panel of 19 signature genes (Pcbp4, Msx2, H1fx, Thop1, Vars2, Myo10, 
2700094K13Rik, Ets1, Pygo2, Adam12, 5730449L18Rik, Rex3, Bdac1, Cair, Cryab, Peg10, 
AU041707, Crmp1, and Ube4b) common between epidermal NCSCs and embryonic NCSCs, 
but distinct from epidermal stem cells that generate keratinocytes, despite sharing the bulge 
as their niche. Some of these genes are related to NC development. For example, Msx2 
regulates cranial NCC differentiation into skeletal lineages (Han et al., 2007; Takahashi et al., 
2001); Ets1 regulates NC formation through the recruitment of an epigenetic regulator to 
repress BMP signaling (Wang et al., 2015) and cardiac NC migration (Gao et al., 2010); and 
Myo10 is critical for cranial NC migration (Nie et al., 2009). Other genes are involved in 
neural/neural-crest related diseases (Thop1, Adam12, Ube4b, and Vars2) (Baertling et al., 
2016; Caren et al., 2006; Pollio et al., 2008; Shao et al., 2014), regulation of Wnt signaling 
pathways (Pygo2) (Belenkaya et al., 2002), and invasiveness (Crmp1, Adam12) (Cai et al., 
2016; Shao et al., 2014). Interestingly, a detailed comparison of gene expression revealed 
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epidermal NCSCs did not express any NC marker genes (Snail1/2, Twist, Pax3, Sox9, nexin, 
Nestin, fibronectin, Wnt5a, Sca-1, Shox2, and Dermo-1) in SKPs (Fernandes et al., 2004; Hu 
et al., 2006), suggesting at least two molecularly distinct populations of NCSCs are located in 
the hair follicle.  
 
In mouse models of spinal cord injury, grafted murine epidermal NCSCs were found to 
integrate with the surrounding host spinal tissue leading to significant improvements in 
sensory connectivity and touch perception (Sieber-Blum et al., 2006). Importantly, even 
though epidermal NCSCs share some stem cell genes with iPSCs, they do not form tumors at 
the grafting site, which is an essential prerequisite for stem cell-based therapies. NC-derived 
Schwann cells are glial cells of the PNS responsible for axonal myelination and ensheathing 
as well as tissue repair following severe nerve damage in spinal cord injury. These glial type 
cells promise to be useful for nerve regeneration by contributing to axon regeneration and 
remyelination. A previous study developed an efficient protocol for generating SKP-derived 
Schwann cells (Biernaskie et al., 2006). Studies showed that transplantation of SKP-derived 
Schwann cells were more effective than SKPs in contributing to the recovery from spinal 
injury, including lesion site bridging effects, increasing the size of spared tissue, reducing 
reactive gliosis, and most importantly, enhancing locomotor recovery (Biernaskie et al., 
2007).  
 
Multipotent SKPs have also been isolated from human neonatal foreskin and adult trunk skin 
(Toma et al., 2005; Wong et al., 2006). These multipotent cells are likely to be of NC origin 
based on the expression of Sox10 and p75NTR (Wong et al., 2006), although they are limited in 
their use in human research. Human epidermal NCSCs located in the bulge of hair follicle, 
similar to their mouse counterparts, are multipotent cells that express markers characteristics 
of NCSCs and iPSCs, and can undergo self-renewal and give rise to all major NC derivatives 
including neurons, osteoblasts/chondrocytes, Schwann cells, and smooth muscle cells 
(Clewes et al., 2011). Importantly, they do not form tumors in vivo even though they express 
stem cell genes, making them attractive candidates for cell-based therapies. Indeed, human 
epidermal NCSCs can be differentiated into clinically relevant cell types including bone cells, 
midbrain dopaminergic neurons (Narytnyk et al., 2014), and Schwann cells that could be 
used in nerve repair (Sakaue and Sieber-Blum, 2015). Whether these differentiated cell types 
can be used for tissue regeneration needs to be evaluated in animal disease models before 
conducting clinical trials.  
		
	 16	
Craniofacial tissue-derived NCSCs 
• Cornea 
In addition to trunk tissue-derived NCSCs, several aforementioned cranial NC-derived tissues 
also contain multipotent NCSCs. One such tissue is the cornea, which is a transparent 
avascular structure that functions to cover the front of the eye and together with the lens helps 
to focus light on the retina. The cornea is composed of three major cellular components: a 
stratified epithelium, a thick collagenous stroma containing keratocytes, and a single layered 
endothelium. The homeostasis and integrity of these components is vital in preserving 
transparency and optical precision. Chick-quail chimeras revealed that quail-derived cranial 
NCCs contributed to the corneal endothelium and keratocytes by producing keratan sulfate 
proteoglycans (KSPGs) that interact with the stromal collagen regulating the collagen fibril 
diameter and spacing required for transparency (Hassell and Birk, 2010). Keratocytes 
undergo division in the fetal stage, withdraw from the cell cycle in newborns, and become 
quiescent throughout the adult life. However, in response to the injury, these non-
proliferative keratocytes can resume migration, mitosis, wound healing, and repair via re-
expression and secretion of extracellular matrix, indicating cellular plasticity (Fini, 1999). 
This was demonstrated by transplantation of quail NC-derived keratocytes from late embryos 
into the early chick embryo, which resulted in the cells following normal NC migratory 
routes and differentiating into NC derivatives, such as smooth muscle, myofibrils, 
keratocytes, and endothelial cells, but not neurons of cranial ganglia and branchial arch 
cartilage, suggesting stromal keratocytes have partially restricted NCSC-derived progenitors 
(Lwigale et al., 2005). This study demonstrated that keratocytes were not terminally 
differentiated, but maintained a degree of plasticity and multipotency. Consistently, putative 
multipotent keratocyte precursor cells (also called cornea-derived precursors, COPs) were 
identified in the corneal stroma of adult mice (Yoshida et al., 2006). Genetic lineage tracing 
using Wnt1-Cre/Floxed-EGFP and P0-Cre/Floxed-EGFP reporter mice showed that COPs 
were of NC origin, but not derived from the BM because they expressed embryonic NC 
marker genes (Twist, Snail1/2, and Sox9). Clonal sphere-forming assay showed that single 
COPs formed spheres, which could be further subcultured for more than 18 passages, 
indicating self-renewal potential. Moreover, COPs demonstrated multipotency and had the 
ability to differentiate into keratocytes, fibroblasts, and myofibroblasts as well as adipocytes, 
chondrocytes and neural cells when cultured in differentiation-inducing media. Human 
corneal stromal stem cells (CSSCs) present in the limbus also exhibited self-renewal capacity 
and broad differentiation potential, as well as appeared to be of NC origin (Du et al., 2005). 
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Consistently, gene array analysis revealed a panel of multipotent mesenchymal stem cell 
(MSC) genes (ABCG2, BMi1, CD166, cKIT, Notch1, Pax6, and Six2) were highly expressed 
in CSSCs, but were weakly expressed in keratocytes. Nonetheless, when cultured in low-
mitogen, ascorbate-containing media, CSSCs differentiated and expressed genes (keratocan, 
ALDH3A1, CXADR, PTDGS, and PDK4) characteristics of keratocytes. Human CSSCs 
injected into corneal stroma of lumican-null mutants (Lum-/-), which exhibit reduced corneal 
transparency due to defects in collagen fibril assembly (Chakravarti et al., 1998), adopted 
keratocytic functions by depositing human extracellular matrix components in the stroma (Du 
et al., 2009). Electron microscopy analysis 3 months post-injection revealed improved 
collagen fibril organization, resulting in restoration of both transparency and thickness of 
Lum-/- corneas. Most importantly, transplanted human CSSCs did not trigger T-cell-mediated 
immune rejection, making them excellent candidates for allogeneic transplantation for the 
treatment of scarred stroma. 
  
• Iris 
Fate mapping analysis using transgenic mice and chick embryos revealed that cranial NCCs 
also contributed to the development of the iris (Gage et al., 2005) (Kikuchi et al., 2011). The 
isolated EGFP+ iris cells from P0-Cre/floxed-EGFP reporter mice formed primary and 
secondary spheres on non-adherent plates, indicating self-renewal capacity. These iris-
derived sphere-forming cells expressed marker genes for neural stem cells (Sox2, Nestin, and 
Musashi) and NCCs (p75NTR, Sox10, Sox9, Snail2, and AP-2β), and were able to differentiate 
into neurons, glia, smooth muscle, and chondrocytes (Kikuchi et al., 2011). These NC-
derived multipotent stem cells, which can be isolated from murine iris and expanded by 
sphere culture, have properties that make them potential sources of cells for regenerative 
therapy for eye diseases.  
 
• Teeth 
Another accessible source of NCSCs can be derived from the dental pulp and periodontal 
ligament in both mouse and human. Dental pulp is located at the center of each tooth encased 
in mineralized dentin and is comprised of connective tissue, odontoblasts, mesenchymal cells, 
nerve fibers, lymphatic, and blood vessels. The primary function of the dental pulp is to 
produce dentin and maintain its biological and physiological vitality. In response to teeth 
eruption, a population of cranial NC-derived dental pulp stem cells (DPSCs)/progenitor cells 
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in the pulp tissue of teeth is induced to differentiate into odontoblasts to form reparative 
dentin, which protects the dental pulp from degradation (Huang et al., 2006; Janebodin et al., 
2011). Consistent with their NC origin, DPSCs expressed NCSC marker genes (e.g., GFAP, 
HNK-1, Nestin, p75NTR, and S-100) (Almushayt et al., 2006). These DPSCs are multipotent 
with the capacity to differentiate into chondrocytes, adipocytes, odontoblasts, and neural-like 
cells in vitro as well as form ectopic dentin and associated pulp tissue in vivo (Gronthos et al., 
2002). In addition, they possess biological properties similar to BM-derived MSC, such as 
fibroblast-like morphology, clonogenicity, and ability to adhere to plastic tissue culture 
dishes, and they expressed MSC surface markers (CD29, CD44, CD59, CD73, CD90, CD105, 
and CD146), but not hematopoietic markers (CD34, CD45, or CD11b) (Liu et al., 2015). 
However, detailed quantitative comparison studies revealed that DPSCs had faster population 
doubling time, higher numbers of stem/progenitor cells, and increased mineralization 
potential compared to BM-MSCs (Alge et al., 2010). Consistently, DPSCs exhibited a higher 
osteogenic potency than BM-MSCs both in vitro and in vivo (Jensen et al., 2016). 
Transplantation of a biocomplex comprised of human DPSCs and a hydroxyapatite tri-
calcium-phosphate paste in parietal defects of immunocompetent rats produced significant 
improvements in the calcification rate and bone mineral density at 8 weeks post-surgery 
compared to the untreated control group (Asutay et al., 2015). Moreover, DPSCs could be 
cryopreserved for 2 years without altering their proliferation rate, viability, morphology, 
surface antigens, level of gene expressions, and osteogenic differentiation capacity, making 
them an attractive cell source for long-term cryopreservation and bone regeneration 
(Papaccio et al., 2006). The DPSCs could also differentiate into other clinically relevant cell 
types in vitro, such as neurons (Gervois et al., 2015) and islet cell aggregates (Govindasamy 
et al., 2011), which could have potential for regenerative therapies in neurological disorders 
and diabetes, respectively.   
 
The periodontal ligament (PDL) is a soft connective tissue embedded between the tooth root 
and the alveolar bone socket, which is also derived from cranial NCCs (Chai et al., 2000), 
Like the dental pulp, PDL contains multipotent NCSCs with characteristics similar to MSCs 
as they are able to self-renew and differentiate into neural and mesenchymal lineages (Seo et 
al., 2004). Consistently, PDL-derived stem cells expressed marker genes of NCCs (Notch1, 
BMP2, Snail1/2, Nestin, and TuJ1), MSC (CD44, CD90, and Vimentin), and ESCs (c-Myc, 
Klf4, Nanog, and Oct4), suggesting that PDL may contain a pluripotent stem cell population. 
Under appropriate culture conditions, PDL could undergo pancreatic differentiation into 
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insulin-producing cells with endodermal lineage (Huang et al., 2009). In addition, PDL-
derived stem cells could be directed to generate retinal progenitors with competence for 
photoreceptor differentiation, underlying their therapeutic potential in retinal cell 
regeneration (Huang et al., 2013). Importantly, both DPSCs and PDL-derived stem cells 
exhibited low immunogenicity as demonstrated in rodent (de Mendonca Costa et al., 2008), 
sheep (Mrozik et al., 2013), and swine models (Ding et al., 2010), which would make them 
promising candidates for allogeneic transplantation. Together dental pulp- and PDL-derived 
stem cells obtained from the readily accessible human teeth material possess powerful ex 
vivo expansion, versatile differentiation potential, and immunomodulatory ability, providing 
a rich source of cells for various tissues regeneration therapies.  
 
• Palatum 
The palate of adult rats was shown to have NC-related stem cells, which expressed markers 
characteristic of both NCSCs and pluripotent ESCs, and they propagated into neurosphere-
like clusters that differentiated efficiently into neurons and glial cells. In addition, mRNAs of 
the four transcription factors (Oct4, Sox2, c-Myc, and Klf4) involved in iPS induction were 
detected in the human palate (Widera et al., 2009). These findings suggest dormant NC-
related stem cells in the palate might be a possible donor source for iPS derivation, and also 
contribute to its highly regenerative capacity following wound injury (Kahnberg and 
Thilander, 1982). However, we still do not know if palate-derived stem cells originated from 
embryonic NCCs, if they can differentiate into other lineages besides neurons and glial cells, 
or if they can undergo self-renewal through multiple passages of neurospheres.    
 
• Oral mucosa 
Although it has been demonstrated that cranial NCCs contribute to the formation of 
mesenchymal tissues of the head and other craniofacial structures (Cordero et al., 2011), it 
was only recently confirmed that Lgr5+ cranial NCCs contribute to the stromal cell 
population in oral mucosa lamina propria (OMLP) using Lgr5-EGFP-ires-CreERT/Rosa26-
Tomato reporter mice. These Lgr5+ cells expressed NCSC markers with the capacity for 
clonal growth and multipotent differentiation (Boddupally et al., 2016). Similar to the palate, 
the rapid healing capacity of oral mucosa and lack of scar formation could be due to the 
existence of a primitive NCSC-derived population in the OMLP. On the other hand, human 
(h) OMLP-derived cell populations exhibited rapid proliferative capacity, expressed ESC and 
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NCSC markers, and had pluripotent potential to differentiate into three germ layers in vitro. 
hOMLP-derived cells treated with dexamethasone (osteogenic inducer) formed tumors 
comprising of both mesodermal and ectodermal tissues when transplanted in severe 
combined immune deficiency mice, demonstrating their capacity to form mesodermal tissues 
in vivo. Some of the tissues formed in tumors were cranial NC derivatives including cartilage 
and bone (Marynka-Kalmani et al., 2010). These findings indicate that hOMLP harbors 
primitive stem cells and NCSC population. Another study demonstrated similar mesodermal 
and ectodermal lineages could be obtained from in vitro differentiation of hOMLP-derived 
pluripotent cells, although an in vivo differentiation assay was not performed (Davies et al., 
2010). A recent study showed that cells isolated from excised human oral mucosa could form 
into spheres in neurosphere culture conditions, and were capable of self-renewal and 
expressed NC-related genes (Abe et al., 2016). These human oral mucosa-derived cells were 
multipotent and capable of differentiating into NC lineages in vitro and generated ectopic 
bone tissues in vivo, indicating they could be a potential source of cells for bone tissue 
regeneration.  
 
Development of experimental approaches to derive NCSCs from pluripotent stem cells 
and somatic cells 
Human NC markers 
Although characterizations of NCSCs from embryonic and adult tissues in animal models 
have provided insights into their molecular and functional properties, little is known about 
the mechanisms of human NC development and the pathology of neurocristopathies. In 
humans, the NC starts to migrate before NT closure as early as embryonic stage 9, around the 
third to fourth week of gestation (O'Rahilly and Muller, 2007). Because of the ethical and 
scientific challenges involved in isolating human fetal NCCs for experimental manipulation, 
these transient structures have remained largely unexplored. Increasing efforts have focused 
on the derivation of NCCs from human (h) ESCs and iPSCs for use in defining the cellular 
and molecular mechanisms governing their specification, migration and differentiation, and 
as a cellular platform for disease modeling and drug screening. The expression of NC genes 
in different stages of human embryo development and in human NCC lines derived from 
pharyngulas have already been documented (Betters et al., 2010; Thomas et al., 2008). These 
studies revealed several commonly expressed NC genes among human and other animal 
models, such as neural plate border specifiers (Pax7, Pax3, and Msx1) and NC progenitors 
(Sox9, Sox10, Snail2, and FoxD3). These genes have been used as markers to identify both 
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mouse (m) ESC- and hESC/iPSC-derived NCCs (Milet and Monsoro-Burq, 2012). 
Consistently, cross-species comparison also showed extensive overlap among human, mouse, 
and avian NCC transcriptomes, though some molecular cascades appeared to be unique to 
humans or mice, which was linked to the plasticity of the NC lineages that engendered 
differences in the derivatives generated between species. In addition, the transcriptional 
profile of hNCCs possessed molecular signatures of hESCs, including but not restricted to the 
expression of transcription factors SOX2, NANOG, and OCT4, indicating hNCCs exhibited 
unique molecular and phenotypic features of pluripotent stem cells (Thomas et al., 2008). In 
agreement with this notion, a recent study in Xenopus demonstrated key NC regulatory 
factors were expressed in blastula animal pole cells and promoted pluripotency in both NC 
and blastula cells (Buitrago-Delgado et al., 2015), suggesting that NCCs may have evolved 
from a subset of blastula animal pole cells retaining activity of the regulatory network 
underlying pluripotency.     
In chick embryos, HNK1 was found to be a marker for migrating NCCs (Tucker et al., 1984), 
but could only label a small population of SOX10+ hNCCs. In contrast, p75NTR could broadly 
mark hNCCs and other non-NC cell types (Betters et al., 2010). Fluorescence-activated cell 
sorting (FACS) using antibodies against both surface markers has been used to enrich hNCCs 
differentiated from a mixed population of cells. In the past decade or so, many approaches 
have been established for the efficient generation of hNCCs and its derivatives from mESCs, 
hESCs, and hiPSCs (Kunisada et al., 2014; Milet and Monsoro-Burq, 2012). Here, we 
highlight key developments in the derivation protocols involving the use of stromal feeder-
layers, an intermediate stage in the formation of neural rosettes or embryoid bodies (Bajpai et 
al., 2009; Elkabetz et al., 2008), and the manipulation of signaling pathways (Table 2, Fig. 2).   
 
Stromal cell-derived inducing activity (SDIA) 
Mizuseki et al. were first to establish the conditions to induce differentiation of mouse and 
primate ESCs into NC-like cells by co-culture with the mouse stromal cell line PA6 and 
exposure to BMP4 after 4 days of co-culture. These ESC-derived NC-like cells could be 
further differentiated into sensory and autonomic lineages with low (0.5 nM) and high (5 nM) 
concentrations of BMP4, respectively (Mizuseki et al., 2003). Using similar PA6 co-culture, 
hESCs were differentiated into hNCCs expressing characteristic marker genes (SNAIL2 and 
SOX9) or into neural progenitors using noggin to inhibit BMP signaling, which could then be 
further differentiated into PNS derivatives such as sensory and sympathetic neurons 
(Brokhman et al., 2008; Pomp et al., 2005). The yield of peripheral sensory neurons was 
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further improved via the formation of hESC-derived neurospheres under non-adhesive 
conditions (Pomp et al., 2008). Combining the PA6 co-culture with FACS allowed 
enrichment of p75NTR+ NCCs within 1 week. These p75NTR-enriched cells formed 
neurospheres with self-renewal capacity and could be differentiated into multiple NC 
lineages including peripheral nerves, glia, and myofibroblastic cells. Importantly, these sorted 
cells migrated and differentiated into NC derivatives when transplanted into chick embryos 
(Jiang et al., 2009). Another co-culture study used the BM-derived stromal cell line ST2 to 
induce differentiation of mESCs into NC-like cells with melanocyte identity as an 
intermediate cell type after sorting against its cell-surface protein, c-Kit. A single c-Kit+ cell 
was able to form colonies containing neurons, glial cells, and melanocytes, demonstrating 
their multipotency (Motohashi et al., 2007; Yamane et al., 1999).  
 
Neural rosettes  
Co-culture of hESCs with MS5 stromal cells resulted in the efficient differentiation of hESCs 
into neuroepithelial-like structures, termed neural rosettes, which expressed markers 
compatible with neural plate identity and showed extensive self-renewal capacity (Perrier et 
al., 2004). Neural rosettes replated on polyornithine/laminin-precoated dishes formed 
p75NTR+HNK1+ hNCSCs, which could be further expanded in the presence of FGF2/EGF and 
directed toward PNS lineages and mesenchymal lineages in serum free and serum conditions, 
respectively. Transplantation of enriched hNCSCs into developing chick and adult mouse 
demonstrated survival, migration, and differentiation compatible with NC identity (Hotta et 
al., 2009; Lee et al., 2007). However, some major drawbacks of these approaches were the 
use of stromal cell lines, in which the secreted factors in the conditioned medium were 
undefined, and the time-consuming nature of obtaining hNCSCs and their derivatives (~21-
40 days). To resolve these issues, microarray studies were conducted that identified several 
growth factors including SHH, WNT5A, TGFβ, and IGF expressed by PA6 (Swistowska et 
al., 2010). The PA6-derived factors together with NC induction medium could efficiently 
induce differentiation of hESCs into neural stem cells via embryoid body formation, which 
subsequently formed p75NTR+ hNCSCs in the periphery of the rosettes (Liu et al., 2012).  
 
Dual-SMAD inhibition  
The efficiency of the generation of hESC-derived neural progenitor cells (NPCs) was further 
improved without the need of a feeder layer, which was made possible by using specific 
SMAD signaling inhibitors (dual-SMAD inhibition) such as noggin and SB 431542 that 
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blocked BMP and Activin A/Nodal signaling, respectively. FACS analysis of the NPC 
population revealed the PAX6+ cells exhibited anterior neural identity, whereas PAX6- cells 
expressed NC markers (Chambers et al., 2009; Curchoe et al., 2010). Consistent with a strong 
requirement for Wnt signaling in early NC induction (Garcia-Castro et al., 2002), 
concomitant activation of WNT signaling using the GSK3β inhibitor BIO combined with 
dual-SMAD inhibition resulted in diverting neural progenitor fate toward 
p75NTR+HNK1+AP2+ NC-like cells. These cells could be clonally propagated and maintained 
for 25 passages, while retaining multipotency to differentiate into peripheral neurons and 
mesenchymal cell types (Avery and Dalton, 2016; Menendez et al., 2011). Subsequent 
optimization of the NC induction conditions revealed a narrow time window (starting at day 
2 of the differentiation protocol) for adding CHIR99021 (Chir), a Wnt signaling agonist that 
selectively inhibits glycogen synthase kinase 3β (GSKβ) (Meijer et al., 2004), which was 
required for the induction of SOX10::eGFP reporter expression in hNCSCs (Lee et al., 2010). 
Delaying Chir treatment until day 4 of differentiation did not support NC specification, 
indicating loss of cell competency to NC-inductive WNT signals. Similar temporal 
suppression of BMP and TGFβ/Activin signaling by treatment with small molecule inhibitors 
at day 2 to 3 was sufficient to specify NC fate. Optimizing NC conditions by timed exposure 
to SMAD inhibitors and the Wnt agonist resulted in the induction of SOX10::eGFP 
expression detectable by flow cytometry on day 6 of differentiation and peaking by day 11. 
In addition, the yield of SOX10::eGFP positive cells was more than 20-fold (~53%) 
compared with the standard dual-SMAD inhibition protocol that only led to low levels of 
spontaneous NC induction (Chambers et al., 2009; Mica et al., 2013). This NC differentiation 
protocol also generated a small amount of melanoblasts (or melanocyte precursors, 9%) 
within the 59% SOX10+ NC precursor population on day 11 of the differentiation. Treatment 
with BMP4 and endothelin 3 (EDN3) on day 6 of the differentiation not only enhanced 
melanoblast yield but also further directed their maturation (Callahan et al., 2016; Fang et al., 
2006; Mica et al., 2013). A recent study has also established a specific melanocytic medium 
to directly differentiation of mouse NCSCs into melanocytes (Shakhova and Sommer, 2015).  
Moreover, hESC-derived SOX10+ NCCs did not exhibit high levels of HOX gene expression, 
indicating their cranial NC identity (Mica et al., 2013). Addition of retinoic acid (RA) into 
the differentiation medium on day 6 shifted the regional NCC identity from anterior to 
posterior vagal fates as demonstrated by the expression of HOXB3 and HOXB5 
characteristic of vagal identity (Chan et al., 2005; Fattahi et al., 2016; Fu et al., 2003). Under 
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these NC optimized conditions, hNCSCs were obtained in 11 days. Further refinement of this 
method using chemically defined medium (CDM) containing minimal growth factor (insulin) 
with inhibitors for TGFβ signaling and GSK3β, but not for BMP signaling, efficiently 
induced multipotent hNCSCs (70%-80%) from hESCs or hiPSCs within ~9 days. The 
induced hNCSCs expressed cranial NC marker genes and could differentiate into corneal 
endothelial cells. In addition, induced hNCSCs could be stably expanded in CDM 
supplemented with EGF and FGF2 for at least 10 passages without significant alteration of 
gene expression profiles (Fukuta et al., 2014). Further refinement simplified the approach by 
eliminating the use of dual-SMAD inhibitors, instead employing low-density cultures of 
dissociated hESCs in defined serum free-media under WNT activation, allowing robust 
induction of cranial NCCs expressing SOX10 (~63%), PAX7 (~78%), TFAP2A (~84%) and a 
panel of NC markers in just 5 days. In contrast to previous protocols, hNCCs generated by 
this method appeared to arise independently not from neural and mesodermal tissues but from 
precursors with an early pre-border state (Leung et al., 2016), suggesting these hNCCs were 
not derived from a neural origin. These findings were further supported by previous 
embryological evidence that NC formed from non-neural ectoderm did not acquire neural 
characteristics (Yardley and Garcia-Castro, 2012). 
 
SOX10-mediated reprogramming 
In addition to generating hNCSCs and their derivatives from hESCs and hiPSCs using 
various culture conditions, a recent major advancement using a single transcription factor, 
SOX10, allowed multipotent induced NCCs (iNCCs) to be generated from human postnatal 
fibroblasts or hESC-derived fibroblasts harboring the SOX10::eGFP reporter (Kim et al., 
2014; Lee et al., 2010). Sox10 broadly marks all NCCs during development, and is essential 
for the maintenance of their multipotency, self-renew, survival, and lineage-specification 
(Britsch et al., 2001; Kim et al., 2003). Using lentiviral-mediated overexpression of SOX10 
combined with extracellular matrix components (laminin/fibronectin) and epigenetic 
modifiers (Aza/VPA), human fibroblasts could be reprogrammed into iNCCs without going 
through the pluripotent intermediate state. Importantly, addition of Chir and BMP into the 
culture medium further increased the yield. These iNCCs had morphological and cellular 
features and expressed NC gene profiles comparable to hESC-derived NCCs. Using in ovo 
and ex vivo transplantation assays further demonstrated the ability of iNCCs to migrate and 
integrate into NC-derivatives, such as the DRG, sympathetic ganglion, and ENS (Kim et al., 
2014). It should be noted, one major drawback of iNCC generation is that lentiviral 
		
	 25	
integration into the host genome may result in tumor formation, which would not be ideal for 
therapeutic applications. Nevertheless, the lineage conversion strategy generating multipotent 
iNCCs provides an accessible platform for studying human NC biology and the pathogenesis 
of neurocristopathies.  
 
 
Neural crest-associated diseases and stem cell therapy 
Genetic mutations causing defective migration, proliferation and differentiation of embryonic 
NCSCs are associated with several congenital disorders or neurocristopathies, many of which 
primarily affect pediatric patients. Because it is not possible to isolate fetal NCSCs in humans, 
hNCSCs harboring mutations associated with these diseases have been induced from patient-
specific hiPSCs. This serves as a powerful cellular platform for disease modeling that can 
contribute to the understanding of the pathogenesis of these disorders and can serve as a 
viable cell source for transplantation therapy and drug screening. More importantly, since 
hNCSCs are derived from the patients, they can be used for autologous transplantation 
without immuno-rejection. 
 
Previous studies in modeling melanocytic-specific disorders used patient-specific derived 
hiPSCs from three distinct genetic syndromes with defects in melanosome vesicle formation 
or trafficking (Callahan et al., 2016; Mica et al., 2013). By using the NC optimized 
conditions with timed exposure to dual-SMAD inhibitors and WNT agonist, patient-iPSCs 
could be directed into NCC fate and then into melanocyte precursors in the presence of BMP 
and END3 signaling. Although mature melanocytes were derived at comparable efficiencies 
from patients and control iPSCs, each of the independently derived iPS clones exhibited 
different degrees of pigmentation defects that faithfully recapitulated the disease-related 
phenotypes from the respective patients.  
 
Familial dysautonomia (FD) is a neurodegenerative autosomal recessive disorder of the PNS 
and is characterized by autonomic dysfunction, including progressive loss of sympathetic and 
sensory neurons leading to gradually diminished pain and temperature sensations. The 
disorder is mainly caused by a germline point mutation in ELP1/IKBKAP (a subunit of the 
Elongator complex), leading to IKBKAP mis-splicing and marked reduction of IKBKAP 
protein expression (Axelrod, 2004). Conditional knockout of Ikbkap in mice NCCs caused 
aberrant neuronal differentiation and early neuronal death (George et al., 2013). To 
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investigate the underlying causes of FD, Lee et al. generated iNCCs from FD skin fibroblasts. 
They showed that FD-derived iNCCs expressed the surface marker CD34 that allows 
segregation of iNCCs from non-reprogrammed cells, but expressed reduced levels of wild-
type IKBKAP and exhibited migration defects compared to the control iNCCs (Kim et al., 
2014). Gene expression profiling studies also revealed common downregulated genes in both 
FD iNCCs and hiPSC-derived hNCCs that were involved in alternative splicing and cell 
migration. Consistently, aberrantly spliced transcripts of MEF2C and PAX3, genes involved 
in determining NC lineages (Bachinski et al., 2010; Wang et al., 2006), were detected in FD 
iNCCs (Lee et al., 2009). The plant hormone kinetin and the small molecule SKF-86466 were 
found to restore the expression of wild-type IKBKAP proteins and peripheral neuron markers 
lost in FD (Lee et al., 2009; Lee et al., 2012).  
 
Another well-studied neurocristopathy, Hirschsprung’s disease (HSCR), also called 
aganglionic megacolon, affects 1 in 5000 newborns (Amiel et al., 2008). Failure of enteric 
NCCs to migrate to the distal intestine results in the absence of NC-derived enteric ganglia 
along the variable length of the intestine, leading to intestinal obstruction with massive 
dilation of the proximal bowel. Depending on the variable length of the intestine affected, 
HSCR can be classified into Short-segment HSCR (S-HSCR) and Long-segment HSCR (L-
HSCR) (Amiel et al., 2008; Brooks et al., 2005). In humans, ten HSCR susceptibility genes 
(RET, SOX10, PHOX2B, EDBRB, END3, ECE1, ZFHX1B, GDNF, NRTN and KIAA1279) 
have been identified (Heanue and Pachnis, 2007). Recent studies on zebrafish showed that 
embryos with transcription factor Meis3 knockdown exhibited colonic aganglionosis (Uribe 
and Bronner, 2015), suggesting that Meis3 may contribute to the pathogenesis of HSCR, but 
this remains to be determined. The standard treatment for HSCR is surgical removal of the 
defective bowel, but for L-HSCR patients, the remaining length of bowel may not be 
sufficient for normal nutrient absorption. A recent alternative treatment for HSCR involves 
the generation of enteric progenitors from hESCs by adding RA into the NC differentiation 
medium (Fattahi et al., 2016) as described in (Mica et al., 2013). Enriched CD49D+ (α4-
integrin) ENS precursors were maintained in 3D spheroids before differentiating into enteric 
neurons in the presence of ascorbic acid and glial cell line-derived neurotrophic factor 
(GDNF) (Fattahi et al., 2016). Mature enteric neurons exhibited a broad range of 
neurotransmitter phenotypes including serotonin-positive, γ-aminobutyric-acid-positive, and 
nitric oxide synthase-positive neurons. In vivo transplantation of hESC-derived enteric 
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progenitors into chick embryos and adult mouse colon showed they could invade into the gut 
region, which confirmed their enteric NC identity. Importantly, engraftment of hESC-derived 
ENS progenitors increased survival rate of HSCR mice bearing mutations in Ednrb, which 
develop megacolon due to aberrant peristalsis (Gariepy et al., 1996). Pepstatin A, identified 
from a small-molecule screen, was shown to restore aberrant migration of EDNRB-/- hESC-
derived enteric NC precursors both in the scratch assay and after transplantation into adult 
mouse colon (Fattahi et al., 2016), demonstrating the ability of this candidate therapeutic 
drug to rescue HSCR-related migration defects.   
Bicuspid aortic valve (BAV) is a congenital heart disease where two of the aortic valvular 
leaflets fuse to form a bicuspid valve instead of a normal tricuspid valve. Patients with BAV 
are at a higher risk of developing thoracic aortic aneurysms (TAA) (Fedak et al., 2005; 
Michelena et al., 2011). The aneurysms associated with BAV commonly involve the 
ascending aorta but not the descending aorta. Fate-mappin  g studies have demonstrated that 
cardiac NCCs contribute to the smooth muscle cells (SMCs) formation in the ascending aorta, 
while the descending aorta is populated by SMCs from the paraxial mesoderm (Majesky, 
2007). A recent study demonstrated that iPSCs from BAV/TAA patients could be 
differentiated into NCCs with high efficiency, but they exhibited defective SMCs formation 
with impaired contraction, reduced TGF-β signaling and increased mTOR signaling. 
Inhibition of mTOR signaling pathway using rapamycin could restore the aberrant SMC 
differentiation (Jiao et al., 2016). These studies demonstrated the utility of patient-specific 
iPSC-derived NCSCs in defining the molecular basis of a disease process without knowing 
the underlying genetic defect responsible for the observed abnormality.  
Concluding remarks and future perspectives 
In the past two decades, advances in molecular biology and functional genomics have 
allowed us to gain a better understanding of how various molecules expressed in different NC 
developmental stages are functionally connected together to form a gene regulatory network 
that defines the formation, migration, and differentiation of NC progenitors. Such basic 
developmental studies are essential for several reasons. First, they provide insights into how 
genes evolved in the emergence of NCCs and their derivatives essential for studying the 
evolution of vertebrates, for example, through modeling the function of the head in terms of 
the shift from filter-feeders to active predators (Kerosuo et al., 2015). Second, increasing 
evidence suggests that genes involved in NC development are often dysregulated in NC-
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derived tumors such as melanoma and neuroblastoma. Understanding the molecular 
mechanisms underlying NC formation, migration, and differentiation could shed light on the 
initiation and progression of NC-related tumors (Maguire et al., 2015). Third, they informs us 
about the identity of extrinsic and intrinsic molecules involved in expanding and maintaining 
hESC/iPSC-derived NCCs/iNCCs and adult tissue-derived NCSCs, and in directing their 
differentiation into specific lineages for use in cell and tissue replacement strategies. For 
example, a recent study demonstrated that chick crestosphere culture conditions could direct 
hESCs to form human crestospheres expressing NC markers that were able to differentiate 
into neural, glial, melanocytic, and mesenchymal tissues (Kerosuo et al., 2015). Fourth, they 
provide gene signatures that allow accurate assessment of the identity, regulatory, and 
developmental state of in vitro NCSCs/progenitors derived by direct differentiation from 
PSCs or by lineage reprogramming from somatic cells.  
 
Although animal models have provided promising results for the development and potential 
use of NCSCs/progenitors for the treatment of many neurocristopathies, some key issues 
need to be addressed. The current differentiation protocols using SOX10::eGFP reporter or 
p75NTR+/HNK1+ enrichment tend to generate hNC precursors with cranial/anterior identity. 
Recent studies demonstrated that addition of RA into NC differentiation medium promoted 
posterior vagal NC identity (Fattahi et al., 2016). Similarly, addition of RA promoted 
specification of trunk NC progenitors, which could be further directed to sympathoadrenal 
lineage in the presence of BMPs (Huang et al., 2016). However, based on the marker 
expressions and the differentiation protocol used in this study, it was not clear if the 
generation of trunk NC progenitors and their derivatives was efficient and whether other 
lineages such as melanocytes and neurons were present in the culture. Further optimization of 
the differentiation protocol and identification of unique surface proteins are needed for the 
enrichment and purification of each NC-derived lineage, respectively. Recently, Simoes-
Costa and Bronner used transcriptomics to reveal unique gene signatures between cranial and 
trunk NC in chick embryos that defined their axial identity. Such information would be 
important for further refinement of the culture conditions required for the differentiation of 
hESCs/iPSCs into axial-specific NC progenitors and their derivatives, particularly if they are 
used in cell therapies for various neurocristopathies.  
Although the ability to generate patient-specific hiPSC-derived NCCs is a powerful tool for 
modeling the pathogenesis of neurocristopathies, these NCCs and their derivatives carry gene 
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mutations that are not ideal for therapeutic application. However, we can now genetically 
correct mutation in patient-derived iPSCs using CRISPR/Cas9, TALENs and ZFNs to restore 
the normal function of specific cell types derived from hNCCs. Even though we can obtain 
highly enriched and genetically corrected NC progenitors for a specific lineage, we still need 
to use animal disease models to assess the extent of their integration after transplantation to 
ensure the NC-derived cells are functionally stable in the long term. On the other hand, non-
viral approaches such as plasmid-driven strategies and small molecule compounds can 
mediate lineage reprogramming of somatic cells into iNCCs that can prevent tumorigenesis 
after transplantation in the host. Overall, these endeavors will ensure hNCCs and their 
derivatives are clinically safe and can be functionally integrated into the host tissue for 
disease treatment. 
Multipotent NSCSs have attracted increasing attention in the field of developmental and stem 
cell biology, because they can be easily obtained from various animal and human adult tissue 
sources for use in research and treatments. The advent of omics technologies and availability 
of high throughput drug screening platforms will be instrumental in expanding our 
understanding of the genetic regulation of hNCCs and their derivatives and will expedite the 
development of patient-specific therapies to treat neurocristopathies.   
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Abbrevations Abbrevations 
(h/m)ESCs (Human/mouse) Embryonic stem cells iNCCs induced neural crest cells 
(h)iPSCs (Human) induced pluripotent stem cells KSPGs keratan sulfate proteoglycans 
(h)NCCs (Human) Neural crest cells MSC Mesenchymal stem cell 
(h)NCSCs (Human) Neural crest stem cells NA Not applicable 
(S/L-)HSCR (Short-segment/Long-segment-) Hirschsprung’s disease N-Cad N-cadherin 
AA Ascorbic acid NPCs Neural progenitor cells 
BM Bone marrow NRG1 Neuregulin1 
BAV Bicuspid aortic valve NSPs Neurospheres 
CB Carotid body NT Neural tube 
CDM Chemically defined medium NTR Nerve growth factor receptor 
Chir Chir CHIR99021 OMLP Oral mucosa lamina propria 
CNS Central nervous system PD Parkinson’s disease 
COPs Cornea-derived precursors PDL Periodontal ligament 
CSSCs Corneal stromal stem cells PNS Peripheral nervous system 
DPSCs Dental pulp stem cells RA Retinoic acid 
DRG Dorsal root ganglia SDIA Stromal-derived inducing activity 
EBs Embryoid bodies Sip1 Smad-interacting protein 1 
ECM Extracellular matrix SKPs Skin-derived precursors  
EDN3 Endothelin 3 SMCs Smooth muscle cells 
EMT Epithelial mesenchymal transition SP Side population 
ENS Enteric nervous system TAA Thoracic aortic aneurysms  
FACS Fluorescence-activated cell sorting WP Whisker pad 
FD Familial dysautonomia 
GDNF Glial-cell-line-derived neurotrophic factor 
 GSKβ  Glycogen synthase kinase 3β 
Table1
List of abbreviations 
Pluripotent cell types Protocols for NCSCs derivation Brief description of methods 
Markers for 
cell sorting 
NC markers 
analyzed NC-derived cell types generated Remarks References 
mESCs (EB5) SDIA PA6 as feeder layer. Treatment with BMP4 from day 4 increased NCC population No Ap2, NCAM 
Sensory and autonomic neurons (Brn3a+/Peri+; 
TH+/Phox2b+/Peri+ ) 
(Mizuseki et al., 
2003) 
hESCs 
(HES-1, HUES, 
HUES 1) 
SDIA hESCs co-cultured with PA6 induced peripheral 
neuronal formation. No 
SOX9, dHAND, 
MSX1, AP2, 
SNAIL2 
Sensory and sympathetic neurons (Brn3a+/Peri+; 
TH+/Peri+ ) 
PA6 cells induced NC-like cells before 
neuronal differentiation. (Pomp et al., 2005) 
hESCs 
(H1, H9) 
SDIA 
Mitotically inactivated MEF as feeder layer. 
Treatment with Wnt3a, SCF, and EDN3 induced 
melanocyte differentiation from hESCs-derived 
EBs on fibronectin 
No SOX10 Melanocytes (PAX3+, TYRP1+, DCT+, MITF+) 
Differentiated melanocyte showed proper 
localization and maker expression after 
grafting into reconstructed human skin. 
(Fang et al., 2006) 
mESCs 
(D3) 
SDIA ST2 as feeder layer. Treatment with RA promoted 
NCCs formation c-Kit+/CD45- 
Sox10, 
Pax3,Snail1/2 
Neuron (Tuj1+), Glial Cells (GFAP+), 
Melanocytes (MITF+) 
C-Kit+ cells showed cell renew capacity and 
were able to follow the NCCs migratory 
pathway after in vivo transplantation. 
(Motohashi et al., 
2007) 
hESCs 
(HES1, HUES9) 
SDIA PA6 as feeder layer.  No AP2/NCAM1 Sensory neurons (Brn3a
+, Peri+) 
Glial cells (PMP-22+, Sox10+) 
Peripheral neurons and NC were observed 
after 1 week of co-culture.  
(Brokhman et al., 
2008) 
hESCs 
(HUES7, HUES9) 
SDIA hESC co-cultured with PA6 generated NSPs expressing NCCs marker under non-adhesive 
conditions. 
No 
SNAIL1, SOX9, 
MSX1, PAX3 
,FOXD3,NCX/HOX
11L1 
Sensory neurons (Brn3a+, Peri+), Glial cells 
(GFAP+) 
PA6-induced hESC-derived NSPs promoted 
peripheral neuronal differentiation. (Pomp et al., 2008) 
hESCs 
(H9, H1) 
SDIA PA6 as feeder layer. FACS-based isolation was 
applied for NCCs enrichment. p75
NTR+ 
SNAIL1/2, HNK1, 
SOX10, AP2 and 
NCAM 
Sensory neurons (Peri+), Glial cells( GFAP+), 
Myofibroblasts (SMA+) 
Transplantation of isolated NCCs in chicken 
and mouse showed proper migration, 
differentiation and proliferation. 
(Jiang et al., 2009) 
hESCs 
(HES3, HES4 and 
ENVY) 
SDIA PA6 as feeder layer. ROCK inhibitor treatment 
promoted NCCs formation. No 
HNK1, SOX8, 
SOX9,SOX10 Enteric neurons (Hu
+), Glial cells (S100B+) 
Transplantation of isolated NCCs in chicken 
and mouse showed proper migration, 
differentiation and proliferation. (Hotta et al., 2009) 
hESCs 
(H9 (WA-09), RUES1-
eGFP48, I-8) 
SDIA 
Neural Rosette 
MS5 as feeder layer. Treatment with 
BMP2/FGF2/EGF promoted NCC populations. 
Different growth factors and culture conditions 
were developed for NCC and its derivatives. 
p75NTR+/ 
HNK1+ 
SOX10, PAX3, 
AP2,ERBB3,SNAIL
2 
Neurons (Peri+,Tuj1+), Schwann cells 
(GFAP+,MBP+), Smooth muscles 
(SM22α+,calponin+), Chondrogenic cell 
(Collagen II+, Aggrecan+), Osteogenic cell 
(ALP+,BSP+) 
Transplantation of hNCSCs into chick embryo 
and adult mouse hosts showed survival, 
migration and differentiation compatible with 
neural crest identity. 
(Lee et al., 2007) 
hESCs 
(H9, H1, and RU-01eGFP 
SDIA 
Neural Rosette MS5 as feeder layer. 
FORSE-/ 
N-CAD+ 
SOX10,PAX3,AP2,
TWIST1,SNAIL2 NA 
Forse1-  neural rosette cells expressed NC 
markers   
(Elkabetz et al., 
2008) 
hESCs  
and iPS cells 
SDIA 
Neural Rosette MS5 as feeder layer. HNK1+ AP2 
Autonomic and sensory neurons 
(ASCL1+,Tuj1+, Brn3a+,Peri+) 
Generation of NCCs and Peripheral neurons 
using FD patient-specific iPS cell. (Lee et al., 2009) 
hESCs 
(H9 and H14) Neural Rosette 
No feeder layer. Rapid neuralization of ESCs 
without Noggin and limited capacity for 
expansion (up to 5 passages). 
No SOX9 NA 
Committed neural progenitor cells are capable 
of differentiation into various CNS cell types 
and NC fates.  
(Bajpai et al., 2009) 
Table 2
Derivation and characterization of NCSCs from pluripotent ESCs/iPSCs and skin fibroblasts.
 NA: Not applicable.  Differentiation of NCCs into different lineages was not demonstrated.
Pluripotent cell types Protocols for NCSCs derivation Brief description of methods 
Markers for 
cell sorting 
NC markers 
analyzed NC-derived cell types generated Rearks References 
hESCs 
(H9) 
Neural Rosette 
No feeder layer. Emigrating hNCCs were 
obtained by plating of hESCs-derived 
neurospheres containing rosette structure on 
fibronectin.  
No PAX3/6,SOX9/10,p75NTR, HNK1 
Autonomic neurons (TH+/Peri+), Sensory neurons 
(BRN3a+/Peri+), Smooth muscle (SMA+), 
Melanocyte (MelanA+), Glial cells (PLP+/GFAP+) 
Inhibition of BMP and Wnt signaling re-
specified NCSCs into CNS cells (Curchoe et al., 2010) 
hESCs (H9/14) 
and iPSCs 
SDIA 
Neural Rosette 
PA6 as feeder layer. Schwann cell 
differentiation was initiated by culturing 
hNCSCs in MesenPRO medium with  
20ng/ml heregulin-β1 for 40 days. 
p75NTR+ SOX9/10, p75
NTR, 
HNK1,CD44 
Neurons (Hu+/HNK1+), Schwann cells 
(S100+/P75NTR+) 
Pure population of Schwann cells were 
generated and myelinated rat dorsal root 
ganglia neurons in vitro. 
(Liu et al., 2012) 
hESCs (WA-09) and 
iPSC lines (iPS-14/27) 
Dual-SMAD 
Inhibition 
Feeder layer and EBs formation were not 
required. Both SB431542 and Noggin induced 
rapid and complete neural differentiation. 
PAX6- AP2, HNK1,PAX7 ,p75NTR Melanocytes (HMB45
+) 
Manipulation of the initial hES-cell 
plating density skewed the ratio of PAX6+ 
CNS and PAX6- NC-like cells. 
(Chambers et al., 2009) 
hESCs (WA-09) and 
iPSC lines (iPS-14/27) 
Dual-SMAD 
Inhibition 
Feeder layer was not required. 
NC differentiation from hESCs using defined 
NSB (KSR medium +SMAD inhibitors 
followed by N2) culture system  
p75NTR +/ 
HNK1+ 
AP2, HNK1, 
PAX7,p75NTR 
Autonomic Neuron (MASH1+/Peri+), Sensory 
neurons (Brn3a+/Peri+), Schwann cells 
(GFAP+,Sox10+), Smooth muscle cells (SMA+), 
Chondrogenic cell (Collagen II+) 
The yield of p75NTR+/HNK1+ precursors 
using the NSB protocol is comparable 
with the yield using the MS5 co-culture 
protocol.  
(Lee et al., 2010) 
hESCs 
and iPSCs 
Dual-SMAD 
Inhibition 
Exposure of hPSCs to WNT-activator (CHIR 
99021) promoted Sox10+ NC population 
formation by day 6. Subsequent treatment of 
BMP4 and EDN3 specified melanocytic 
lineage.  
c-Kit+ 
/SOX10+ 
SOX10,HNK1 
,p75NTR 
Melanocyte (SOX10+/ MITF+) ,Melanosomal 
(TYRP1+ /PMEL+) 
Melanocytes derived from patient-specific 
iPSCs reproduced pigmentation defects.  (Mica et al., 2013) 
hESCs 
(H9) 
Dual-SMAD 
Inhibition 
Addition of RA promoted vagal NCCs 
formation. 
CD49D+
/SOX10+ 
HOXB2-9, 
FOXD3,TBX2,PAX
3,SOX10,TFAT2A/
B,PHOX2A/B 
Enteric neurons (NOS+,5-
HT+,GABA+,SSST+,TH+,CHAT+) 
In vivo engraftment of hESC-derived ENC 
progenitors rescued HSCR mice. (Fattahi et al., 2016) 
hESCs (WA01, WA09) 
iPSCs (Y6 iPSC, RIV9 
iPSCs) 
Dual-SMAD 
Inhibition 
Low-density of hESCs/iPSCs were cultured in 
defined serum free media under WNT 
activation. 
No SOX10, Pax7, TFAP2A 
hNCCs differentiated via an early pre-
border state   (Leung et al., 2016) 
Sox10::eGFP  
reporter hESCs 
SOX10-mediated 
reprogramming 
SOX10::eGFP fibroblasts were treated with 
dox-inducible lentiviruses containing SOX10, 
ECM, epiM and Chir 99021 or BMP4 
Sox10::eGFP+
CD34+
HNK1, p75NTR 
FOXD3, AP2 
Chondrocytes, osteoblasts, peripheral neurons 
(HuC/D+ (ELAVL3/4), TUJ1+ (TUBB3) PRPH+, 
ISL1+), glial precursors (S100β+ GFAP+) and 
melanoblasts (MITF+,SOX10+) 
Neurons (Tuj1+, Peri+, BRN3A+, MAP2+, Syn+), 
Schwann cells (GFAP+/S100B+/PRX+, MPZ+), 
Smooth muscle (SMA+), Melanocytes 
(MITF+,TYRS+), chondrocytes (Collagen II+, 
Aggrecan+), adipocytes (PPAR+), osteocytes (ALP+, 
BSP+ 
FD patient fibroblasts-derived iNC cells 
displayed defects in cellular migration and 
alternative mRNA splicing.  
(Kim et al., 2014) 
Figure Legends 
 
Figure 1. Schematic diagram showing different adult tissue sources from which NCSCs are 
derived.  
 
 
Figure 2. Schematic illustration of four different protocols for the derivation of NCSCs from 
pluripotent stem cells and skin fibroblasts.  
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